(XHR) Xenia Hotels & Resorts - Ratings and Ratios
Luxury Hotels, Upscale Resorts, Hotel Portfolio, Rooms
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.86% |
| Yield on Cost 5y | 4.29% |
| Yield CAGR 5y | 14.94% |
| Payout Consistency | 74.1% |
| Payout Ratio | 81.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 29.4% |
| Value at Risk 5%th | 43.0% |
| Relative Tail Risk | -11.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.13 |
| Alpha | -26.06 |
| CAGR/Max DD | 0.02 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.520 |
| Beta | 1.275 |
| Beta Downside | 1.265 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.47% |
| Mean DD | 13.42% |
| Median DD | 13.11% |
Description: XHR Xenia Hotels & Resorts November 13, 2025
Xenia Hotels & Resorts, Inc. (NYSE:XHR) is a self-advised, self-administered REIT that concentrates on luxury and upper-upscale hotels and resorts located in the top 25 U.S. lodging markets and premier leisure destinations. The portfolio comprises 30 properties, totaling 8,868 rooms across 14 states, and is operated or licensed by major brands such as Marriott, Hyatt, Fairmont, Kimpton, Loews, Hilton, and The Kessler Collection.
As of Q3 2024, Xenia’s average occupancy hovered around 71%, with a RevPAR growth of 4.2% year-over-year, reflecting the rebound in discretionary travel and strong demand for upscale accommodations. The REIT’s weighted-average ADR sits near $210, benefitting from a 6% annual increase in corporate travel budgets and a robust leisure-to-business travel mix. Forward-looking, the sector remains sensitive to macro-drivers like consumer confidence, inflation-adjusted discretionary spending, and the trajectory of the Federal Reserve’s interest-rate policy, which directly impacts cap-rate compression and refinancing risk.
For a deeper dive into XHR’s valuation metrics and scenario analysis, you might find ValueRay’s interactive dashboards useful.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (56.4m TTM) > 0 and > 6% of Revenue (6% = 64.5m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 2.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 15.46% (prev 12.36%; Δ 3.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 185.7m > Net Income 56.4m (YES >=105%, WARN >=100%) |
| Net Debt (1.23b) to EBITDA (234.0m) ratio: 5.28 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.25 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (95.2m) change vs 12m ago -6.55% (target <= -2.0% for YES) |
| Gross Margin 22.18% (prev 24.49%; Δ -2.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 37.24% (prev 35.48%; Δ 1.75pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 1.21 (EBITDA TTM 234.0m / Interest Expense TTM 84.9m) >= 6 (WARN >= 3) |
Altman Z'' -0.56
| (A) 0.06 = (Total Current Assets 299.3m - Total Current Liabilities 133.2m) / Total Assets 2.87b |
| (B) -0.23 = Retained Earnings (Balance) -663.6m / Total Assets 2.87b |
| (C) 0.04 = EBIT TTM 102.5m / Avg Total Assets 2.89b |
| (D) -0.40 = Book Value of Equity -662.4m / Total Liabilities 1.64b |
| Total Rating: -0.56 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 54.72
| 1. Piotroski 4.50pt |
| 2. FCF Yield 3.43% |
| 3. FCF Margin 8.43% |
| 4. Debt/Equity 1.21 |
| 5. Debt/Ebitda 5.28 |
| 6. ROIC - WACC (= -2.31)% |
| 7. RoE 4.65% |
| 8. Rev. Trend 44.17% |
| 9. EPS Trend 25.33% |
What is the price of XHR shares?
Over the past week, the price has changed by +0.43%, over one month by +8.79%, over three months by -0.36% and over the past year by -5.31%.
Is XHR a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the XHR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.8 | 5.9% |
| Analysts Target Price | 14.8 | 5.9% |
| ValueRay Target Price | 14.5 | 4% |
XHR Fundamental Data Overview November 26, 2025
P/E Trailing = 24.6607
P/E Forward = 63.2911
P/S = 1.3056
P/B = 1.1209
Beta = 1.267
Revenue TTM = 1.07b USD
EBIT TTM = 102.5m USD
EBITDA TTM = 234.0m USD
Long Term Debt = 1.42b USD (from longTermDebt, last quarter)
Short Term Debt = 4.43m USD (from shortTermDebt, last fiscal year)
Debt = 1.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.23b USD (from netDebt column, last quarter)
Enterprise Value = 2.64b USD (1.40b + Debt 1.42b - CCE 188.2m)
Interest Coverage Ratio = 1.21 (Ebit TTM 102.5m / Interest Expense TTM 84.9m)
FCF Yield = 3.43% (FCF TTM 90.6m / Enterprise Value 2.64b)
FCF Margin = 8.43% (FCF TTM 90.6m / Revenue TTM 1.07b)
Net Margin = 5.24% (Net Income TTM 56.4m / Revenue TTM 1.07b)
Gross Margin = 22.18% ((Revenue TTM 1.07b - Cost of Revenue TTM 836.4m) / Revenue TTM)
Gross Margin QoQ = 5.65% (prev 29.27%)
Tobins Q-Ratio = 0.92 (Enterprise Value 2.64b / Total Assets 2.87b)
Interest Expense / Debt = 1.53% (Interest Expense 21.8m / Debt 1.42b)
Taxrate = 4.50% (-684.0k / -15.2m)
NOPAT = 97.9m (EBIT 102.5m * (1 - 4.50%))
Current Ratio = 2.25 (Total Current Assets 299.3m / Total Current Liabilities 133.2m)
Debt / Equity = 1.21 (Debt 1.42b / totalStockholderEquity, last quarter 1.18b)
Debt / EBITDA = 5.28 (Net Debt 1.23b / EBITDA 234.0m)
Debt / FCF = 13.63 (Net Debt 1.23b / FCF TTM 90.6m)
Total Stockholder Equity = 1.21b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.97% (Net Income 56.4m / Total Assets 2.87b)
RoE = 4.65% (Net Income TTM 56.4m / Total Stockholder Equity 1.21b)
RoCE = 3.89% (EBIT 102.5m / Capital Employed (Equity 1.21b + L.T.Debt 1.42b))
RoIC = 3.75% (NOPAT 97.9m / Invested Capital 2.61b)
WACC = 6.05% (E(1.40b)/V(2.83b) * Re(10.71%) + D(1.42b)/V(2.83b) * Rd(1.53%) * (1-Tc(0.04)))
Discount Rate = 10.71% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.77%
[DCF Debug] Terminal Value 67.04% ; FCFE base≈64.6m ; Y1≈58.2m ; Y5≈49.9m
Fair Price DCF = 6.31 (DCF Value 598.3m / Shares Outstanding 94.8m; 5y FCF grow -12.43% → 3.0% )
EPS Correlation: 25.33 | EPS CAGR: 84.42% | SUE: 0.17 | # QB: 0
Revenue Correlation: 44.17 | Revenue CAGR: 4.07% | SUE: 0.10 | # QB: 0
Additional Sources for XHR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle